SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-03-002998
Filing Date
2003-05-13
Accepted
2003-05-13 11:52:32
Documents
10
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS INC. b46496ape10vq.htm 10-Q 165775
3 EX-10.1 CREDIT AGREEMENT b46496apexv10w1.txt EX-10.1 155493
4 EX-10.2 TERM NOTE b46496apexv10w2.txt EX-10.2 7698
5 EX-10.3 SECURITY AGREEMENT - ARIAD PHARMACEUTICALS b46496apexv10w3.txt EX-10.3 76377
6 EX-10.4 SECURITY AGREEMENT - ARIAD CORPORATION b46496apexv10w4.txt EX-10.4 75868
7 EX-10.5 SECURITY AGREEMENT/ARIAD GENE THERAPEUTICS b46496apexv10w5.txt EX-10.5 76134
8 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b46496apexv99w1.txt EX-99.1 3254
9 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER b46496apexv99w2.txt EX-99.2 3336
10 EX-99.3 CERTIFICATION PURSUANT TO SECTION 906 b46496apexv99w3.txt EX-99.3 1940
11 COURTESY PDF b46496ape10vqxpdfy.pdf 10-Q 433859
  Complete submission text file 0000950135-03-002998.txt   1002545
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-76486 | Film No.: 03694505
SIC: 2836 Biological Products, (No Diagnostic Substances)